Impact of Clinical Pharmacist Interventions in Management of Diabetes in Primary Care in Saudi Arabia
Article Sidebar
-
Clinical Pharmacist, Diabetes, Primary Care, Intervention, Quality of Life, Pharmaceutical Care
Abstract
The study aimed to identify the impact and effectiveness of clinical pharmacist intervention on the management and overall quality of life of diabetic patients. Two cross-sectional studies using SF36 Health Survey, involving physicians and pharmacists at the Ambulatory Care Department in Riyadh, Saudi Arabia. Diabetic patients showed significant improvements in their QoL in terms of general health, energy and fatigue, pain scores, and social, emotional, and physical functions. Moreover, PC was found to have a significant impact on diabetes related QoL along with various outcome indicators, such as HbA1c, random blood sugar, and lipid profile in such patients. Additionally, satisfactory knowledge, good practice in identifying prescription errors were found among pharmacists. This study reveals that clinical pharmacists are valuable members of interdisciplinary primary care teams in ambulatory care. This can positively impact glycemic control in patients with type 2 diabetes and improve their quality of life. Also, the current study presented that a satisfactory extent of pharmaceutical care by an ambulatory clinical pharmacist was effective in improving HbA1c in patients with diabetes. A clinical pharmacist in ambulatory care was found to be eminent and of an added value to the patients, physicians, and healthcare team.
Full text article
References
Ahmad, A. D., Elnour, A. A., Yousif, M. A., Farah, F. H., Akasha, H. A., Abasaeed, A., Shehab, A., Kalbani, N. A., Nuaimim, S. A., Bhagavathula, A. S., Shehab, O. A., Amoodi, A. A. A. 2015. Pharmacist’s interventions to improve clinical outcomes in patients with type 2 diabetes mellitus: Nyala City, South Darfur State, Sudan. International Journal of Diabetes in Developing Countries, 35(4):578–587.
Al-Mazroui, N. R., Kamal, M. M., Ghabash, N. M., Yacout, T. A., Kole, P. L., McElnay, J. C. 2009. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. British Journal of Clinical Pharmacology, 67(5):547–557.
Al-Quteimat, O. M., Amer, A. M. 2016. Evidence-based pharmaceutical care: The next chapter in pharmacy practice. Saudi Pharmaceutical Journal, 24(4):447–451.
Aldossari, K. K., Aldiab, A., Al-Zahrani, J. M., Al-Ghamdi, S. H., Abdelrazik, M., Batais, M. A., Javad, S., Nooruddin, S., Razzak, H. A., El-Metwally, A. 2018. Prevalence of Prediabetes, Diabetes, and Its Associated Risk Factors among Males in Saudi Arabia: A Population-Based Survey. Journal of Diabetes Research, 2194604.
Alhabib, S., Aldraimly, M., Alfarhan, A. 2016. An evolving role of clinical pharmacists in managing diabetes: Evidence from the literature. Saudi Pharmaceutical Journal, 24(4):441–446.
Ali, M., Schifano, F., Robinson, P., Phillips, G., Doherty, L., Melnick, P., Laming, L., Sinclair, A., Dhillon, S. 2012. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabetic Medicine, 29(9):e326–e333.
Barber, N., Wilson, A., Willson, A. 1999. Churchill’s clinical pharmacy survival guide. Churchill Livingstone. ISBN: 978-0443055362.
Bellary, S., O’Hare, J. P., Raymond, N. T., Gumber, A., Mughal, S., Szczepura, A., Kumar, S., Barnett, A. H. 2008. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. The Lancet, 371(9626):1769–1776.
Clifford, R. M., Batty, K. T., Davis, T. M. E., Davis, W., Stein, G., Stewart, G., Plumridge, R. J. 2011. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. International Journal of Pharmacy Practice, 10(2):85–89.
Clifford, R. M., Davis, W. A., Batty, K. T., Davis, T. M. 2005. Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes. Diabetes Care, 28(4):771–776.
Contopoulos-Ioannidis, D. G., Karvouni, A., Kouri, I., Ioannidis, J. P. A. 2009. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ, 338:a3006.
Correr, C. J., Melchiors, A. C., Fernandez-Llimos, F., Pontarolo, R. 2011. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. International Journal of Clinical Pharmacy, 33(2):273–280.
Cranor, C. W., Christensen, D. B. 2003. The Asheville Project: Factors Associated with Outcomes of a Community Pharmacy Diabetes Care Program. Journal of the American Pharmaceutical Association (1996), 43(2):160–172.
Davis, T. M., Clifford, R. M., Davis, W. A., Batty, K. T. 2005. The role of pharmaceutical care in diabetes management. The British Journal of Diabetes and Vascular Disease, 5(6):352–356.
Farsaei, S., Sabzghabaee, A. M., Zargarzadeh, A. H., Amini, M. 2011. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. Journal of Research in Medical Sciences, 16(1):43–49.
Irons, B. K., Lenz, R. J., Anderson, S. L., Wharton, B. L., Habeger, B., Anderson, H. G. 2002. A Retrospective Cohort Analysis of the Clinical Effectiveness of a Physician-Pharmacist Collaborative Drug Therapy Management Diabetes Clinic. Pharmacotherapy, 22(10):1294–1300.
Korcegez, E. I., Sancar, M., Demirkan, K. 2017. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial. Journal of Managed Care and Specialty Pharmacy, 23(5):573–582.
Krass, I., Dhippayom, T. 2013. Pharmaceutical care–impact on quality of life in patients with type 2 diabetes: a review. Clinical Audit, 17.
Krass, I., Mitchell, B., Song, Y. J. C., Stewart, K., Peterson, G., Hughes, J., Smith, L., White, L., Armour, C. 2011. Diabetes Medication Assistance Service Stage 1: Impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Medicine, 28(8):987–993.
Merks, P., Swieczkowski, D., Jaguszewski, M. 2016. Patients’ perception of pharmaceutical services available in a community pharmacy among patients living in a rural area of the United Kingdom. Pharmacy Practice, 14(3):774.
Sriram, S., Chack, L. E., Ramasamy, R., Ghasemi, A., Ravi, T. K., Sabzghabaee, A. M. 2011. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. Journal of Research in Medical Sciences, 16(Suppl 1):S412–S418.
Suppapitiporn, S., Chindavijak, B., Onsanit, S. 2005. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand, 88(Suppl 4):S134–S141.
Vlcek, J., Malý, J., Dosedel, M. 2009. Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy. Vnitrni Lekarstvi, 55(4):384–388.
Wagner, E. H., Grothaus, L. C., Sandhu, N., Galvin, M. S., McGregor, M., Artz, K., Coleman, E. A. 2001. Chronic Care Clinics for Diabetes in Primary Care: A system-wide randomized trial. Diabetes Care, 24(4):695–700.
Ware, J. E., Sherbourne, C. D. 1992. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6):473–483.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.